Search Results for: PERSONALIZED MEDICINE Targeted Personalized Therap
Articles
June 29, 2013
Bayer AG Strikes $520-Million Collaboration With Seattle Genetics, Inc. June 29, 2013
Seattle Genetics, Inc. recently announced it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare. Under the...
May 24, 2013
ApoCell Announces Delivery of First Prototypes of ApoStream CTC Isolation Technology May 24, 2013
ApoCell, Inc. recently announced that the first prototypes of its ApoStream circulating tumor cell (CTC) isolation system have been delivered...
April 30, 2013
FORMULATION DEVELOPMENT - Trends & Opportunities in Particle Design Technologies - Life Sciences & Biopharma in the Spotlight April 30, 2013
Frost & Sullivan Analyst, Cecilia Van Cauwenberghe, MS, examines the observed trends in particle design and engineering technologies, as well as the main factors and opportunities driving the principal technological advances in the biopharmaceutical industry.
April 8, 2013
US Nanotechnology Drug Delivery Market Forecast to Grow Significantly Through 2016 April 8, 2013
Research activities in healthcare have changed significantly in recent years. There has been a paradigm shift away from blockbusters drugs...
February 25, 2013
2/27/2012 February 25, 2013
BASF & Bend Research Sign Bioavailability Agreement BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate...
February 17, 2013
2/20/2013 February 17, 2013
Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of...
September 16, 2012
9/19/2012 September 16, 2012
PharmaTelevision Spotlights Aptalis' Year in Review FDA approvals, revenue gain, and organic business growth are just a few of the...
September 16, 2012
Life Technologies to Partner With Bristol-Myers Squibb September 16, 2012
Life Technologies Corporation recently announced the company has entered into a Master Development Agreement with Bristol-Myers Squibb Company for current...
October 27, 2011
11/01/2011 October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...
September 11, 2011
9/13/2011 September 11, 2011
Evotec & Roche to Develop Compound That Could Slow AD Progression Evotec AG and Roche AG recently announced they have...
September 1, 2011
9/6/2011 September 1, 2011
Jennerex's Virus-Based Drug Targets & Infects Tumors Jennerex, Inc. recently announced the publication of clinical data on its lead product...
March 27, 2011
3/29/2011 March 27, 2011
Champions Biotechnology Announces Technology Collaboration With CephalonChampions Biotechnology, Inc. recently announced the signing of a technology collaboration agreement with Cephalon,...
